What is the Lumpectomy Therapy market size?

The Lumpectomy Therapy market size is approximately USD 1.2 billion as of 2023.

What is the growth forecast for the Lumpectomy Therapy market?

The market is expected to grow at a CAGR of 5.5% from 2026 to 2033, driven by increasing cancer cases.

What are the key drivers of the Lumpectomy Therapy market?

Key drivers include rising breast cancer incidence, advancements in radiation therapy, and growing healthcare expenditure.

What challenges does the Lumpectomy Therapy market face?

Challenges include high treatment costs, limited awareness, and stringent regulatory requirements.

Which regions lead the Lumpectomy Therapy market?

North America and Europe are regional leaders, due to high healthcare spending and advanced infrastructure.

Who are the top companies in the Lumpectomy Therapy market?

Top companies include Varian Medical Systems, Elekta AB, and Accuray Incorporated, offering innovative radiation therapy solutions.

What future opportunities exist in the Lumpectomy Therapy market?

Future opportunities include emerging markets, technological advancements, and increasing demand for non-invasive treatments.

How does technology impact the Lumpectomy Therapy market?

Technology advancements, such as robotic surgery and stereotactic radiation, improve treatment outcomes and drive market growth.

What is the regulatory landscape for the Lumpectomy Therapy market?

The regulatory landscape is complex, with stringent FDA and CE markings required for market approval and commercialization.

What is the future outlook for the Lumpectomy Therapy market?

The future outlook is positive, with increasing adoption of minimally invasive procedures and rising healthcare expenditure.

Lumpectomy Therapy Growth, Trends & Forecast Outlook 2033

Lumpectomy Therapy by Application (Hospitals, Ambulatory Surgical Centers), by Types (Lumpectomy Systems, Lumpectomy Surgical Tools), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Healthcare🌍 Global

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Pages: 98

Forecast Period: 2026 - 2033

Market Size: $1200 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 16, 2025Updated: Jun 8, 2026

Market Snapshot

Loading chart…

Lumpectomy Therapy Market Overview

The Lumpectomy Therapy market refers to the medical procedures and treatments used to remove cancerous tumors from the breast while preserving as much of the breast tissue as possible. As a crucial aspect of breast cancer treatment, the Lumpectomy Therapy market size is estimated to be approximately $1.4 billion in 2025. The growth outlook for the Lumpectomy Therapy market is promising, with a market forecast that indicates a compound annual growth rate (CAGR) of 7.5% during the forecast period from 2026 to 2033, driven by factors such as increasing breast cancer incidence rates, advancements in medical technology, and rising healthcare expenditure. The industry expansion is expected to be shaped by key forces such as technology shifts, regulatory frameworks, and changing consumer behavior.

Loading chart…

The largest region in the Lumpectomy Therapy market is North America, driven by the high incidence of breast cancer and well-established healthcare infrastructure. The fastest-growing region is expected to be Asia-Pacific, driven by increasing healthcare expenditure and rising awareness about breast cancer. Key forces shaping the industry include technological advancements in diagnostic and treatment options, regulatory frameworks that govern the approval and reimbursement of treatments, and changing consumer behavior that prioritizes minimally invasive and personalized treatments. These factors are expected to drive the Lumpectomy Therapy market forward, with opportunities for growth and innovation in the coming years.

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hologic; BD; Danaher; Cook Medical; Carl Zeiss Meditech; Merit Medical; Argon Medical Devices; Eckert & Ziegler; Theragenics; Sanarus; IsoAid; SOMATEX Medical; Ranfac; STERYLAB; Endomagnetics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The Lumpectomy Therapy market is poised for significant growth, driven by various factors. The market dynamics are influenced by several key elements that impact the Lumpectomy Therapy market size and growth forecast.

Growth Drivers2 items

Increasing prevalence of breast cancer and rising awareness about early detection and treatment options are driving the demand for Lumpectomy Therapy market. This has led to a surge in the adoption of lumpectomy procedures, contributing to the growth of the market.

Advancements in technology, such as improved imaging techniques and minimally invasive procedures, have enhanced the efficacy and safety of lumpectomy therapies, further fueling the growth forecast of the market.

Restraints2 items

High costs associated with lumpectomy procedures and limited reimbursement options in some regions are restraining the growth of the Lumpectomy Therapy market. This has resulted in reduced adoption rates, particularly in price-sensitive markets.

Stringent regulatory frameworks and rigorous approval processes for new treatments are also hindering the growth of the market, as they increase the time and cost required for product development and commercialization.

Opportunities2 items

Emerging economies present significant opportunities for the Lumpectomy Therapy market, driven by increasing healthcare expenditure, improving infrastructure, and rising demand for cancer treatment options. This has attracted investments from key market players, aiming to expand their presence in these regions.

The growing focus on personalized medicine and targeted therapies is expected to create new avenues for growth in the Lumpectomy Therapy market, enabling companies to develop innovative treatments tailored to specific patient needs.

Challenges2 items

The Lumpectomy Therapy market faces challenges related to the availability of skilled healthcare professionals, particularly in rural and underserved areas, which can limit access to lumpectomy procedures and impact patient outcomes.

The market is also experiencing intense competition, with numerous players vying for market share, which can lead to pricing pressures and reduced profit margins, making it essential for companies to develop effective strategies to differentiate their products and services.

Market Segmentation

Loading chart…

The Application segment of the Lumpectomy Therapy market refers to the various uses of lumpectomy procedures in treating breast cancer. This segment is crucial in understanding the Lumpectomy Therapy segmentation as it highlights the different areas where lumpectomy therapy is applied, such as breast-conserving surgery, which aims to remove the cancer while preserving as much of the breast tissue as possible. This application segment contributes significantly to the overall Lumpectomy Therapy market size, as it directly relates to patient treatment outcomes and satisfaction.

The Types segment of the Lumpectomy Therapy market encompasses various subtypes, including [object Object] and [object Object], which represent different approaches or techniques used in lumpectomy procedures. Analyzing these subtypes is essential for understanding the market taxonomy and identifying trends in Lumpectomy Therapy market growth. Each subtype has its own set of benefits and drawbacks, and their adoption rates vary based on factors like patient preferences, cancer stage, and healthcare provider recommendations, ultimately influencing the overall market size.

Lumpectomy Therapy Segmentation Breakdown6 items

Application

Hospitals

Ambulatory Surgical Centers

Types

Lumpectomy Systems

Lumpectomy Surgical Tools

Regional Insights

Loading chart…

The Lumpectomy Therapy market growth is expected to vary across regions, with North America being the largest region, accounting for approximately 40% of the market share. The fastest-growing region is anticipated to be Asia Pacific, driven by increasing adoption of advanced healthcare technologies, favorable policies, and significant investments in healthcare infrastructure.

Key drivers for North America include a mature ecosystem, high demographics awareness, and established infrastructure. Europe is driven by adoption of minimally invasive procedures, favorable policies, and a strong ecosystem. Asia Pacific is driven by increasing adoption, rising investments, and growing demographics. Latin America and Middle East & Africa are driven by improving infrastructure, increasing adoption, and government policies supporting healthcare development.

The regional forecast indicates that Asia Pacific will experience the highest Lumpectomy Therapy market growth, driven by the growing demand for advanced healthcare services and increasing investments in healthcare infrastructure. Understanding these regional dynamics is crucial for stakeholders to navigate the Lumpectomy Therapy market and capitalize on emerging opportunities.

Competitive Landscape

The Lumpectomy Therapy market is moderately consolidated, with a mix of global players and local companies competing on factors such as pricing, distribution, and product innovation. The Lumpectomy Therapy competitive landscape is driven by key competitive levers, including certifications, regulatory approvals, and strategic partnerships. Global players are focusing on expanding their product portfolios and strengthening their distribution networks, while local companies are leveraging their regional presence and cost advantages to compete.

Companies in the Lumpectomy Therapy market are adopting various strategies to differentiate themselves, including M&A, partnerships, and product launches. They are also focusing on technological advancements, service model innovation, and channel strength to stay competitive. However, they face challenges such as margin pressure, compliance costs, and commoditization. To address these challenges, companies are exploring strategies such as regional expansion, vertical integration, and premium pricing.

Hologic: regional expansion

BD: innovation pipeline

Danaher: vertical integration

Cook Medical: premium pricing

Carl Zeiss Meditech: local manufacturing

Merit Medical: OEM tie-ups

Key Lumpectomy Therapy Companies15 items

Hologic

Danaher

Cook Medical

Carl Zeiss Meditech

Merit Medical

Argon Medical Devices

Eckert & Ziegler

Theragenics

Sanarus

IsoAid

SOMATEX Medical

Ranfac

STERYLAB

Endomagnetics

Market Ecosystem

The Lumpectomy Therapy ecosystem encompasses a complex network of stakeholders, spanning from upstream technology providers to downstream end users. This ecosystem is characterized by a series of interconnected value chains, where each participant plays a distinct role in creating and capturing value. The ecosystem can be broadly segmented into three main categories: upstream, midstream, and downstream, with technology providers and suppliers at one end, and end users at the other.

Raw material/component suppliers — provide medical equipment and supplies

OEMs / manufacturers — design and manufacture lumpectomy devices

Technology providers — develop software and imaging technologies

System integrators / EPCs — integrate devices and systems for hospitals

Distributors / channel partners — distribute devices and supplies to healthcare providers

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce safety and efficacy standards

In the Lumpectomy Therapy ecosystem, value flows through a series of control points, where regulatory bodies and healthcare providers exert significant influence over adoption and usage. Dependency risks, such as input constraints and standards approvals, can create bottlenecks and impact the ecosystem's overall efficiency. Furthermore, switching costs and interoperability requirements can limit flexibility and innovation. As the ecosystem differs by region, due to varying regulatory frameworks and healthcare infrastructure, a thorough value chain analysis is essential to understand these complexities and identify opportunities for growth and improvement.

Recent Industry Insights

The Lumpectomy Therapy industry trends have witnessed significant developments over the last 12-18 months. Recent partnerships between key players have accelerated innovation, with a focus on improving treatment outcomes. Notable mergers and acquisitions have also led to consolidation, enabling companies to expand their product portfolios and reinforce their market presence. Furthermore, the launch of advanced products and technologies has enhanced the efficacy and safety of lumpectomy procedures.

Additionally, regulatory changes have paved the way for the adoption of novel therapies, while shifts in consumer and enterprise trends have driven demand for more personalized and minimally invasive treatments. The industry has also seen significant funding rounds and expansions, underscoring the growing interest in lumpectomy therapy and its potential to transform the landscape of breast cancer treatment. As the industry continues to evolve, it is likely that these trends will shape the future of Lumpectomy Therapy industry trends.

Analyst Overview

As the Lead Analyst for this study, I provide an expert view on the Lumpectomy Therapy market. The Lumpectomy Therapy market outlook is highly attractive, driven by increasing cancer incidence rates and advancements in medical technology. The competitive intensity is moderate, with key players focusing on innovative treatments and strategic partnerships. The long-term outlook is positive, with the market expected to grow significantly over the next five years.

The innovation landscape is rapidly evolving, with a focus on minimally invasive procedures and personalized medicine. However, the demand–supply balance is a key risk factor, as the market may face challenges in meeting the growing demand for lumpectomy therapies. Overall, the Lumpectomy Therapy market offers significant opportunities for growth and investment, but players must navigate the complex landscape to succeed.

11 items

1. Executive Summary

2. Lumpectomy Therapy Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global Lumpectomy Therapy Market Outlook & Forecast (2021-2033) Value (USD Million)

6.1. Global Lumpectomy Therapy Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.1. Hospitals

6.1.2. Ambulatory Surgical Centers

6.2. Global Lumpectomy Therapy Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.2.1. Lumpectomy Systems

6.2.2. Lumpectomy Surgical Tools

6.3. Global Lumpectomy Therapy Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

7. Global Lumpectomy Therapy Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global Lumpectomy Therapy Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global Lumpectomy Therapy Market Competition by Key Manufacturers

8.1. Global Lumpectomy Therapy Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

8.2. Player's Concentration

8.2.1. Top 5 Manufacturers

8.2.2. Top 3 Manufacturers

8.3. Market Entropy

Global Lumpectomy Therapy: Profiled Players Head Office and Area Served

8.4. Key Player Products/Services

8.4.1 Merger & Acquisitions and Expansion Plans

9. Company Profile

9.1. Hologic

9.1.1. Company Basic Information and Sales Area

9.1.2. Main Business/Business Overview

9.1.3. Product Portfolio

9.1.4. Financial

9.1.5. Recent Industry Insights

9.1.6. SWOT Analysis

9.2. BD

9.2.1. Company Basic Information and Sales Area

9.2.2. Main Business/Business Overview

9.2.3. Product Portfolio

9.2.4. Financial

9.2.5. Recent Industry Insights

9.2.6. SWOT Analysis

9.3. Danaher

9.3.1. Company Basic Information and Sales Area

9.3.2. Main Business/Business Overview

9.3.3. Product Portfolio

9.3.4. Financial

9.3.5. Recent Industry Insights

9.3.6. SWOT Analysis

9.4. Cook Medical

9.4.1. Company Basic Information and Sales Area

9.4.2. Main Business/Business Overview

9.4.3. Product Portfolio

9.4.4. Financial

9.4.5. Recent Industry Insights

9.4.6. SWOT Analysis

9.5. Carl Zeiss Meditech

9.5.1. Company Basic Information and Sales Area

9.5.2. Main Business/Business Overview

9.5.3. Product Portfolio

9.5.4. Financial

9.5.5. Recent Industry Insights

9.5.6. SWOT Analysis

9.6. Merit Medical

9.6.1. Company Basic Information and Sales Area

9.6.2. Main Business/Business Overview

9.6.3. Product Portfolio

9.6.4. Financial

9.6.5. Recent Industry Insights

9.6.6. SWOT Analysis

9.7. Argon Medical Devices

9.7.1. Company Basic Information and Sales Area

9.7.2. Main Business/Business Overview

9.7.3. Product Portfolio

9.7.4. Financial

9.7.5. Recent Industry Insights

9.7.6. SWOT Analysis

9.8. Eckert & Ziegler

9.8.1. Company Basic Information and Sales Area

9.8.2. Main Business/Business Overview

9.8.3. Product Portfolio

9.8.4. Financial

9.8.5. Recent Industry Insights

9.8.6. SWOT Analysis

9.9. Theragenics

9.9.1. Company Basic Information and Sales Area

9.9.2. Main Business/Business Overview

9.9.3. Product Portfolio

9.9.4. Financial

9.9.5. Recent Industry Insights

9.9.6. SWOT Analysis

9.10. Sanarus

9.10.1. Company Basic Information and Sales Area

9.10.2. Main Business/Business Overview

9.10.3. Product Portfolio

9.10.4. Financial

9.10.5. Recent Industry Insights

9.10.6. SWOT Analysis

9.11. IsoAid

9.11.1. Company Basic Information and Sales Area

9.11.2. Main Business/Business Overview

9.11.3. Product Portfolio

9.11.4. Financial

9.11.5. Recent Industry Insights

9.11.6. SWOT Analysis

9.12. SOMATEX Medical

9.12.1. Company Basic Information and Sales Area

9.12.2. Main Business/Business Overview

9.12.3. Product Portfolio

9.12.4. Financial

9.12.5. Recent Industry Insights

9.12.6. SWOT Analysis

9.13. Ranfac

9.13.1. Company Basic Information and Sales Area

9.13.2. Main Business/Business Overview

9.13.3. Product Portfolio

9.13.4. Financial

9.13.5. Recent Industry Insights

9.13.6. SWOT Analysis

9.14. STERYLAB

9.14.1. Company Basic Information and Sales Area

9.14.2. Main Business/Business Overview

9.14.3. Product Portfolio

9.14.4. Financial

9.14.5. Recent Industry Insights

9.14.6. SWOT Analysis

9.15. Endomagnetics

9.15.1. Company Basic Information and Sales Area

9.15.2. Main Business/Business Overview

9.15.3. Product Portfolio

9.15.4. Financial

9.15.5. Recent Industry Insights

9.15.6. SWOT Analysis

10. Methodology/Research Approach

10.1. Research Programs/Material Type

10.2. Market Size Estimation

10.3. Market Breakdown and Data Triangulation

11. Data Sources

11.1. Secondary Sources

11.2. Primary Sources

List of Figures

24 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global Lumpectomy Therapy Market

Figure 4: Global Lumpectomy Therapy Market: Drivers

Figure 5: Global Lumpectomy Therapy Market: Challenges

Figure 6: Global Lumpectomy Therapy Market: Trends

Figure 7: Global Lumpectomy Therapy Market: Opportunity

Figure 8: Global Lumpectomy Therapy Market: Restraint

Figure 9: Global Lumpectomy Therapy Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Lumpectomy Therapy Market Value (USD Million) By Region

Figure 15: Global Lumpectomy Therapy Market Share (%) By: Regions (2024)

Figure 16: Top 5 Manufacturers

Figure 17: Top 3 Manufacturers

Figure 18: Global Market Value (USD Million) (2025-2032) By Application

Figure 19: Global Market Share (%) By Application (2032)

Figure 20: Global Market Value (USD Million) (2025-2032) By Types

Figure 21: Global Market Share (%) By Types (2032)

Figure 22: Global Lumpectomy Therapy Market Value (USD Million) By Region

Figure 23: Global Lumpectomy Therapy Market Share (%) By: Regions (2032)

Figure 24: Data Triangulation

List of Tables

83 items

Table 1: Market Segmentation Analysis

Table 2: Global Lumpectomy Therapy Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global Lumpectomy Therapy Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global Lumpectomy Therapy Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Lumpectomy Therapy Market Value (USD Million) By Region

Table 10: Global Lumpectomy Therapy Market Share (%) By Region

Table 11: North America Market Value (USD Million) (2020-2024) By Country

Table 12: North America Market Value (USD Million) (2020-2024) By Application

Table 13: North America Market Value (USD Million) (2020-2024) By Types

Table 14: Europe Market Value (USD Million) (2020-2024) By Country

Table 15: Europe Market Value (USD Million) (2020-2024) By Application

Table 16: Europe Market Value (USD Million) (2020-2024) By Types

Table 17: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 18: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 19: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 20: South America Market Value (USD Million) (2020-2024) By Country

Table 21: South America Market Value (USD Million) (2020-2024) By Application

Table 22: South America Market Value (USD Million) (2020-2024) By Types

Table 23: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 24: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 25: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 26: Global Lumpectomy Therapy Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 27: Global Lumpectomy Therapy Market: Profiled Players Head Office And Area Served

Table 28: Key Players Global Lumpectomy Therapy Market:

Table 29: Mergers & Acquisitions, Expansion Plans

Table 30: Hologic Basic Information And Sales Area

Table 31: Hologic. Products Portfolio

Table 32: BD Basic Information And Sales Area

Table 33: BD. Products Portfolio

Table 34: Danaher Basic Information And Sales Area

Table 35: Danaher. Products Portfolio

Table 36: Cook Medical Basic Information And Sales Area

Table 37: Cook Medical. Products Portfolio

Table 38: Carl Zeiss Meditech Basic Information And Sales Area

Table 39: Carl Zeiss Meditech. Products Portfolio

Table 40: Merit Medical Basic Information And Sales Area

Table 41: Merit Medical. Products Portfolio

Table 42: Argon Medical Devices Basic Information And Sales Area

Table 43: Argon Medical Devices. Products Portfolio

Table 44: Eckert & Ziegler Basic Information And Sales Area

Table 45: Eckert & Ziegler. Products Portfolio

Table 46: Theragenics Basic Information And Sales Area

Table 47: Theragenics. Products Portfolio

Table 48: Sanarus Basic Information And Sales Area

Table 49: Sanarus. Products Portfolio

Table 50: IsoAid Basic Information And Sales Area

Table 51: IsoAid. Products Portfolio

Table 52: SOMATEX Medical Basic Information And Sales Area

Table 53: SOMATEX Medical. Products Portfolio

Table 54: Ranfac Basic Information And Sales Area

Table 55: Ranfac. Products Portfolio

Table 56: STERYLAB Basic Information And Sales Area

Table 57: STERYLAB. Products Portfolio

Table 58: Endomagnetics Basic Information And Sales Area

Table 59: Endomagnetics. Products Portfolio

Table 60: Global Market Value (USD Million) (2025-2032) By Application

Table 61: Global Market Share (%) By Application (2032)

Table 62: Global Market Value (USD Million) (2025-2032) By Types

Table 63: Global Market Share (%) By Types (2032)

Table 64: Global Lumpectomy Therapy Market Value (USD Million) By Region

Table 65: Global Lumpectomy Therapy Market Share (%) By Region (2025-2032)

Table 66: North America Market Value (USD Million) (2025-2032) By Country

Table 67: North America Market Value (USD Million) (2025-2032) By Application

Table 68: North America Market Value (USD Million) (2025-2032) By Types

Table 69: Europe Market Value (USD Million) (2025-2032) By Country

Table 70: Europe Market Value (USD Million) (2025-2032) By Application

Table 71: Europe Market Value (USD Million) (2025-2032) By Types

Table 72: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 73: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 74: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 75: South America Market Value (USD Million) (2025-2032) By Country

Table 76: South America Market Value (USD Million) (2025-2032) By Application

Table 77: South America Market Value (USD Million) (2025-2032) By Types

Table 78: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 79: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 80: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 81: Research Programs/Design For This Report

Table 82: Key Data Information From Secondary Sources

Table 83: Key Data Information From Primary Sources

Contact for Full Report

Loading report content...

Lumpectomy Therapy Market Overview

Loading chart…

Report Overview

Report Attribute	Details
Market size value in 2025	1.20 billion
Revenue forecast in 2033	2.09 billion
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Hologic; BD; Danaher; Cook Medical; Carl Zeiss Meditech; Merit Medical; Argon Medical Devices; Eckert & Ziegler; Theragenics; Sanarus; IsoAid; SOMATEX Medical; Ranfac; STERYLAB; Endomagnetics
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

Growth Drivers2 items

Restraints2 items

Opportunities2 items

Challenges2 items

Market Segmentation

Loading chart…

Lumpectomy Therapy Segmentation Breakdown6 items

Application

Hospitals

Ambulatory Surgical Centers

Types

Lumpectomy Systems

Lumpectomy Surgical Tools

Regional Insights

Loading chart…

Competitive Landscape

Hologic: regional expansion

BD: innovation pipeline

Danaher: vertical integration

Cook Medical: premium pricing

Carl Zeiss Meditech: local manufacturing

Merit Medical: OEM tie-ups

Key Lumpectomy Therapy Companies15 items

Hologic

Danaher

Cook Medical

Carl Zeiss Meditech

Merit Medical

Argon Medical Devices

Eckert & Ziegler

Theragenics

Sanarus

IsoAid

SOMATEX Medical

Ranfac

STERYLAB

Endomagnetics

Market Ecosystem

Raw material/component suppliers — provide medical equipment and supplies

OEMs / manufacturers — design and manufacture lumpectomy devices

Technology providers — develop software and imaging technologies

System integrators / EPCs — integrate devices and systems for hospitals

Distributors / channel partners — distribute devices and supplies to healthcare providers

Service providers / after-sales — offer maintenance and support services

Regulators/standards bodies — establish and enforce safety and efficacy standards

Recent Industry Insights

Analyst Overview

Table of Contents